Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone
Sign Up to like & getrecommendations! Published in 2020 at "Advances in Therapy"
DOI: 10.1007/s12325-020-01260-x
Abstract: Introduction Prostate cancer (PC) is the second leading cause of cancer death among US men and accounts for considerable healthcare expenditures. We evaluated economic outcomes in men with chemotherapy-naïve metastatic castration-resistant PC (mCRPC) treated with… read more here.
Keywords: cause; enzalutamide abiraterone; treated enzalutamide; castration ... See more keywords
Which traits affect how long patients with advanced prostate cancer live when treated with enzalutamide?
Sign Up to like & getrecommendations! Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2022-0661
Abstract: WHAT IS THIS SUMMARY ABOUT? This is a summary of a research article originally published in European Journal of Cancer. The PROSPER study involved men who had a type of advanced prostate cancer called nonmetastatic… read more here.
Keywords: affect long; prostate cancer; long patients; treated enzalutamide ... See more keywords